Among the clinical trials assessing the efficacy of this antioxidant (Table 8), a pilot study evaluated whether the combination of HT, omega-3 fatty acids, and curcumin would reduce CRP and musculoskeletal symptoms in breast cancer patients receiving adjuvant hormonal therapies. The gene discussed is CRP; the disease is breast carcinoma.